Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
Ultragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be used for in adults and children 10 and up. The new drug ...